Cytotoxicity of common solvents used in liquid nicotine formulations
Ended Awarded Last action
- Contract number
- HHSF22301006T
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6 Part of Lovelace Biomedical Research Institute
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,149,919
Award facts
- Opportunity
-
- 900000000 Solicitation number
- Contract value 100% obligated
- $1,149,919.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Albuquerque, NM 87108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,149,919 |
About this award
This is a delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit organization, for a project titled "CYTOTOXICITY OF COMMON SOLVENTS USED IN LIQUID NICOTINE FORMULATIONS". The contract has a potential value of $1,149,919.00 and a completion date of April 15, 2021. This delivery order is part of a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle called "In Vivo Toxicology of Tobacco 2015-2020". LBERI, a subsidiary of the Lovelace Biomedical Research Institute, has extensive experience in areas such as inhalation toxicology, infectious disease modeling, and medical countermeasure testing. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSF22301006T?
HHSF22301006T was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 11, 2017.
How much is contract HHSF22301006T worth?
The government has obligated $1,149,919 on HHSF22301006T.
Is contract HHSF22301006T an order under another contract?
Yes. HHSF22301006T is a delivery order under HHSF223201510001I, an indefinite delivery contract, on In Vivo Toxicology of Tobacco 2015-2020.
Was contract HHSF22301006T competed?
The extent of competition for HHSF22301006T was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award